| scholarly article | Q13442814 |
| P50 | author | Marzieh Darvishi | Q85282736 |
| P2093 | author name string | Taher Taheri | |
| AliReza Delshad | |||
| Taki Tiraihi | |||
| Seyed A Mesbah-Namin | |||
| P2860 | cites work | Spinal cord injury: a systematic review of current treatment options | Q24631225 |
| Emerging therapies for acute traumatic spinal cord injury | Q27022007 | ||
| Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats | Q27324438 | ||
| Spinal cord injury reveals multilineage differentiation of ependymal cells | Q27333067 | ||
| Pharmacological approaches to repair the injured spinal cord | Q28235760 | ||
| Reactive astrocytes protect tissue and preserve function after spinal cord injury | Q28248202 | ||
| Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo | Q28481548 | ||
| A sensitive and reliable locomotor rating scale for open field testing in rats | Q29619624 | ||
| A comparison of adenosine A2A agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits | Q30439661 | ||
| Ascending central canal dilation and progressive ependymal disruption in a contusion model of rodent chronic spinal cord injury | Q33297820 | ||
| Targeting prolyl endopeptidase with valproic acid as a potential modulator of neutrophilic inflammation | Q33623637 | ||
| Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury | Q33733772 | ||
| Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis | Q33760104 | ||
| Somatosensory-evoked potentials as an indicator for the extent of ultrastructural damage of the spinal cord after chronic compressive injuries in a rat model. | Q33823369 | ||
| Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. | Q34132516 | ||
| Acute spinal cord injury, part I: pathophysiologic mechanisms | Q34391038 | ||
| Pathological changes in the white matter after spinal contusion injury in the rat | Q34405218 | ||
| In vivo conversion of astrocytes to neurons in the injured adult spinal cord | Q34406755 | ||
| The role of steroids in acute spinal cord injury: an evidence-based analysis | Q34503161 | ||
| Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury | Q34871124 | ||
| Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice | Q35212541 | ||
| Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion | Q35764127 | ||
| Up-regulation of 5-HT2 receptors is involved in the increased H-reflex amplitude after contusive spinal cord injury | Q35768264 | ||
| Update on pharmaceutical trials in acute spinal cord injury. | Q35918240 | ||
| The neuroprotective effect of treatment of valproic Acid in acute spinal cord injury | Q36041142 | ||
| Plasticity in ascending long propriospinal and descending supraspinal pathways in chronic cervical spinal cord injured rats | Q36193859 | ||
| Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury | Q36265462 | ||
| Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury | Q36368251 | ||
| The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury | Q36476846 | ||
| Therapeutic interventions after spinal cord injury. | Q36542728 | ||
| Effects of pro-inflammatory cytokines in experimental spinal cord injury | Q48658688 | ||
| Electron microscopic study of the progeny of ependymal stem cells in the normal and injured spinal cord | Q48713466 | ||
| Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury. | Q50548465 | ||
| Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. | Q50707768 | ||
| Experimental neoplastic spinal cord compression: effect of anti-inflammatory agents and glutamate receptor antagonists on vascular permeability. | Q50880307 | ||
| Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes. | Q51868556 | ||
| The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. | Q54179139 | ||
| A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. | Q54606960 | ||
| Valproic Acid Promotes Neurite Outgrowth in PC12 Cells independent from Regulation of the Survival of Motoneuron Protein | Q60229692 | ||
| Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis | Q70356193 | ||
| Therapeutic time window for methylprednisolone in spinal cord injured rat | Q72991628 | ||
| Effect of nimodipine and N-acetylcysteine on lipid peroxidation after experimental spinal cord injury | Q74587143 | ||
| Experimental study on MRI evaluation of the course of cervical spinal cord injury | Q78152448 | ||
| Localization of bone marrow stromal cells in injured spinal cord treated by intravenous route depends on the hemorrhagic lesions in traumatized spinal tissues | Q80143036 | ||
| Prominent microglial activation in the early proinflammatory immune response in naturally occurring canine spinal cord injury | Q84562393 | ||
| Early administration of L-arginine in experimental acute spinal cord injury impairs long-term motor function recovery | Q84699160 | ||
| Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents | Q36645808 | ||
| Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations | Q36672603 | ||
| Effects of valproic acid, a histone deacetylase inhibitor, on improvement of locomotor function in rat spinal cord injury based on epigenetic science. | Q36694368 | ||
| The role of extracellular matrix in CNS regeneration | Q36707967 | ||
| KSRP: a checkpoint for inflammatory cytokine production in astrocytes | Q36776184 | ||
| Silver diagnosis in neuropathology: principles, practice and revised interpretation | Q36777421 | ||
| Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons | Q36965800 | ||
| Spinal cord injury: emerging beneficial role of reactive astrocytes' migration | Q37146886 | ||
| Don't fence me in: harnessing the beneficial roles of astrocytes for spinal cord repair. | Q37280456 | ||
| Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon | Q37315987 | ||
| Transcriptional control of the inflammatory response | Q37622051 | ||
| Inflammation and gliosis in neurological diseases – clinical implications | Q37799890 | ||
| Emerging concepts in myeloid cell biology after spinal cord injury | Q37852601 | ||
| Repertoire of microglial and macrophage responses after spinal cord injury | Q37889633 | ||
| Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. | Q38017625 | ||
| BDNF: the career of a multifaceted neurotrophin in spinal cord injury | Q38043818 | ||
| Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. | Q38055564 | ||
| Inflammatory pathways in spinal cord injury. | Q38065001 | ||
| The therapeutic role of interleukin-10 after spinal cord injury | Q38111457 | ||
| Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets | Q39447956 | ||
| A review of magnetic resonance imaging in spinal trauma | Q40650922 | ||
| Ki-B5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections | Q41695566 | ||
| Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus | Q42065483 | ||
| Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells. | Q42366379 | ||
| Regional differences in astrocyte activation in HIV-associated dementia. | Q42495728 | ||
| Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation | Q43531421 | ||
| Short-Term and medium-term effects of spinal cord tract transections on soleus H-reflex in freely moving rats | Q43563621 | ||
| Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia | Q44269727 | ||
| Reaction of spinal cord central canal cells to cord transection and their contribution to cord regeneration | Q44347438 | ||
| Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties | Q44674787 | ||
| Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition | Q44695995 | ||
| Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats | Q44935785 | ||
| Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats | Q45191278 | ||
| Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. | Q45244360 | ||
| Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury | Q45751518 | ||
| The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid. | Q45916268 | ||
| Transdifferentiation of bone marrow stromal cells into cholinergic neuronal phenotype: a potential source for cell therapy in spinal cord injury | Q46104110 | ||
| Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats | Q46513959 | ||
| Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury | Q46668732 | ||
| Loss of astrocytic domain organization in the epileptic brain. | Q46681558 | ||
| An experimental study of the neuroprotective effect of FK506 on acute spinal cord injury in dogs | Q46728169 | ||
| Long-term effects of methylprednisolone following transection of adult rat spinal cord | Q48177004 | ||
| Ependymal cell reactions in spinal cord segments after compression injury in adult rat. | Q48391251 | ||
| Velocity-dependent ankle torque in rats after contusion injury of the midthoracic spinal cord: time course | Q48449320 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2319-2333 | |
| P577 | publication date | 2014-09-10 | |
| P1433 | published in | Neurochemical Research | Q15716728 |
| P1476 | title | Decreased GFAP expression and improved functional recovery in contused spinal cord of rats following valproic acid therapy | |
| P478 | volume | 39 |
| Q38652105 | Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury. |
| Q26739120 | HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases |
| Q48277987 | Therapeutic Effect of Curcumin and Methylprednisolone in the Rat Spinal Cord Injury |
| Q91960405 | VPA/PLGA microfibers produced by coaxial electrospinning for the treatment of central nervous system injury |
Search more.